Treatment of Early PD: Treat It Early! Thursday, July 23, 2009 7:00 PM - 8:00 PM ET)
This segment features Dr. Mark Lew focusing on Early Diagnosis and Treatment of Parkinson's Disease. This activity is intended for neurologists, pharmacists, and other medical professionals with a specific interest in the management of Parkinson's disease.
Upon completion of this Teleconference, participants should be able to:
Mark Lew, MD, FAAN Professor of Neurology Director, Division of Movement Disorders Vice-Chair Department of Neurology Keck/USC School of Medicine Los Angeles, CA
Mark F. Lew, MD, received his medical degree from George Washington University in Washington DC, where he also served his Internship in Internal Medicine. He completed his Residency in Neurology at Los Angeles County & University of Southern California Medical Center and his Fellowship in Movement Disorders at the University of Southern California in Los Angeles. He is a Fellow of the American Academy of Neurology and holds Board Certification from the American Board of Psychiatry and Neurology.
Dr Lew joined the faculty of the Keck School of Medicine of the University of Southern California in 1991, where he now holds the position of Professor of Neurology, Vice Chair of the department of Neurology and Director of the Division of Movement Disorders. At present, he is also the Director of the Movement Disorders Clinic at Los Angeles County+University of Southern California Medical Center.
Dr Lew is currently focusing on research in new pharmacologic treatments for Parkinson's disease. In addition, he is conducting clinical trials using new forms of botulinum toxin to treat focal dystonias. He is a Participating Scientist of both the Parkinson's Study Group and the Dystonia Study Group. Dr Lew is an active member of the Dystonia Medical Research Foundation, the Executive Committee of the Dystonia Study Group, the American Academy of Neurology, the Movement Disorder Society, the Medical Advisory Committee of the Musicians with Dystonia Program, the ACP Medicine Peer Review Board and a member of the WE MOVE education committee.
He is an ad hoc reviewer for Neurology, JNNP, and Movement Disorders. In addition, his own original clinical and research articles and abstracts have been published in such prestigious journals as JAMA, Science, Movement Disorders, Neurology, Annals of Neurology, American Journal of Psychiatry, Archives of Neurology, Journal of the American Geriatrics Society, Expert Reviews in Neurotherapeutics, Issues in Law and Medicine, Neurosurgery, Human Brain Mapping, American Journal of Human Genetics, Clinical Journal of Pain, Clinical Neuropharmacology, Neurologic Clinics, Neurobiology of Aging, Current Medical Research and Opinion, Pharmacotherapy, Journal of Neurological Sciences, and Expert Review of Neurotherapeutics.
Disclosure: Speaker – Boehringer-Ingelheim, GlaxoSmithKline, Allergan, Teva, Solstice. dvisor / Consultant – Solstice, Teva, BI, Novartis, Valeant, Ipsen, Schering Plough, GlaxoSmithKline, Solvay, Ovation. Researcher – BI, Teva, GlaxoSmithKline, Kyowa, Solstice, Novartis, Schwarz Pharma/UCB, Ipsen, NIH, Eisai, Mentor, Solvay, Schering Plough.
Physicians:
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cine-Med and Astute Technology. Cine-Med is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Cine-Med, Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists:
Cine-Med is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is accredited for 0.1 CEU (1.0 contact hour) of continuing education credit. ACPE Universal Number 0399-999-09-016-H01-P. Activity type: knowledge-based.
How to get CE credit:
To receive credit, participants must view the webcast, register on this site, and successfully complete the post-test and evaluation (successful passing grade >=70%). Certificates can be printed on line.